semaglutide bowel issues Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system Weighing the Risks: Small Bowel

The PROMIS-10 GMH T-score discriminated only between individuals with and without depression

The study also found that these associations held true even when accounting for factors such as sex and the type of mental health diagnosis at study entry

Through careful management and patient-centered approaches, healthcare providers can navigate these complexities to improve outcomes for patients with concurrent diabetes and mental health conditions

Available from: Chen H, Leng X, Liu S, Zeng Z, Huang F, Huang R, et al

A mixture of postbiotics/tyndallized probiotics reduces trimethylamine (TMA) in trimethylaminuria models: Evidence from in vitro and in vivo studies